 What do a solar panel installer; a database software contractor; and a pharmaceutical company specializing in ear, nose, and throat treatments have in common? Yesterday, Sunnova announced that it has priced a secondary offering of 10 million shares 11.5 million, if underwriters exercise their overallotment option at a per-share price of 25. 